The fecal mycobiome in non-alcoholic fatty liver disease

Microbiota and Fatty Liver Disease—the Known, the Unknown, and the Future

(2020) Sonja Lang et al.   Cell Host & Microbe

Prediction of advanced fibrosis in non-alcoholic fatty liver disease using gut microbiota-based approaches compared with simple non-invasive tools

(2020) Sonja Lang et al.   Scientific Reports

Distinct signatures of gut microbiome and metabolites associated with significant fibrosis in non-obese NAFLD

(2020) Giljae Lee et al.   Nature Communications

NASH in Lean Individuals

(2019) Ramy Younes et al.   SEMINARS IN LIVER DISEASE

Fungi participate in the dysbiosis of gut microbiota in patients with primary sclerosing cholangitis

(2019) Sara Lemoinne et al.   GUT

Intestinal fungal dysbiosis and systemic immune response to fungi in patients with alcoholic hepatitis

(2019) Sonja Lang et al.   HEPATOLOGY

Establishing microbial composition measurement standards with reference frames

(2019) James T. Morton et al.   Nature Communications

Editorial: The 20% Rule of NASH Progression: The Natural History of Advanced Fibrosis and Cirrhosis due to NASH

(2019) Rohit Loomba et al.   HEPATOLOGY

Intestinal fungi contribute to development of alcoholic liver disease

(2017) An-Ming Yang et al.   JOURNAL OF CLINICAL INVESTIGATION

Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis

(2017) Anna M. Diehl et al.   NEW ENGLAND JOURNAL OF MEDICINE

High-Fat Diet Changes Fungal Microbiomes and Interkingdom Relationships in the Murine Gut

(2017) Timothy Heisel et al.   mSphere

Epidemiology and outcomes of bloodstream infection in patients with cirrhosis

(2014) Michele Bartoletti et al.   JOURNAL OF HEPATOLOGY

Spontaneous fungal peritonitis: a severe complication in patients with advanced liver cirrhosis

(2013) S. Y. Hwang et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Epidemiology and Clinical Manifestations of Mucormycosis

(2012) George Petrikkos et al.   CLINICAL INFECTIOUS DISEASES

It only takes one to do many jobs: Amphotericin B as antifungal and immunomodulatory drug

(2012) Ana C. Mesa-Arango et al.   Frontiers in Microbiology

Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years

(2010) V. W.-S. Wong et al.   GUT

Presence of Anti-Microbial Antibodies in Liver Cirrhosis – A Tell-Tale Sign of Compromised Immunity?

(2010) Maria Papp et al.   PLoS One

Candida colonisation as a source for candidaemia

(2009) L.N. Miranda et al.   JOURNAL OF HOSPITAL INFECTION